In conclusion, MetHb and COHb seem to be elevated in COVID-19 patients, with a dynamic following the disease progression. MetHb and COHb measurements should be regularly assessed in COVID-19 patients, for example with blood gas analysis (which includes a CO-oximetry module), conventional CO-oximeters or by continuous CO-oximetry.